| Title | Investing in Global Health Systems: Sustaining Gains, Transforming Lives |
| Author(s) | Institute of Medicine; Board on Global Health; Committee on Investing in Health Systems in Low- and Middle-Income Countries |
| Editors | Gillian J. Buckley, John E. Lange, E. Anne Peterson |
| Publisher | National Academies Press |
| Year | 2014 |
| Edition | 1st edition |
| Language | English |
| Pages | 137 |
| ISBN | 9780309311694 |
| Genre | Public Health, Health Policy, International Relations |
| Size | 2 MB |
| Extension |
Summary
Investing in Global Health Systems: Sustaining Gains, Transforming Lives is a consensus report published by the Institute of Medicine (now the National Academy of Medicine) in 2014 through the National Academies Press. The report was produced by the Committee on Investing in Health Systems in Low- and Middle-Income Countries, co-chaired by Ambassador John E. Lange and Dr. E. Anne Peterson, and edited by Gillian J. Buckley, Lange, and Peterson [citation:8][citation:10]. It addresses a pivotal question in global health policy: after more than two decades of substantial American investment in disease-specific programs, how should the United States adapt its foreign assistance strategy to ensure that gains are sustained and that developing countries can eventually assume ownership of their own health systems? The report argues that health systems strengthening—rather than continued reliance on vertical, disease-focused programming—is the necessary next step for effective and sustainable development assistance.
The central conceptual framework of the report revolves around the tension between vertical and horizontal health programming. Vertical programs, which target specific diseases or patient groups, have achieved notable successes, most prominently through the President's Emergency Plan for AIDS Relief (PEPFAR) [citation:2][citation:3]. However, the committee contends that protecting these achievements and preparing for future challenges—including rapidly shifting disease burdens and pandemic threats—requires the judicious integration of vertical programs with robust local health systems. A strong health system, comprising a trained workforce, reliable information systems, adequate infrastructure, and effective management, serves as the foundation for both routine care and emergency response [citation:2]. The report emphasizes that the same investments that improve daily health services also build the capacity to respond to crises, a point underscored by the concurrent Ebola outbreak in West Africa at the time of the report's release [citation:2].
The report offers a detailed analysis of the changing landscape of global poverty and its implications for aid strategy. It notes that the majority of the approximately one billion people living in extreme poverty now reside in middle-income countries, where foreign assistance may be neither needed nor welcome, while others live in fragile states where political instability and weak infrastructure complicate the effective use of aid [citation:3][citation:7]. These realities demand a more nuanced approach than simply increasing funding for disease-specific programs. The committee recommends that Congress direct more health aid toward health systems building, with three crucial components: emphasizing technical cooperation and country ownership over long time horizons, leveraging the United States' comparative advantage in science and technology through investment in global health research and professional training, and requiring rigorous external impact evaluations for projects involving innovation or new service delivery models [citation:2].
The intended audience for this report includes government decision-makers, particularly those in the U.S. Congress and executive agencies responsible for foreign assistance, as well as policymakers in partner countries, global health practitioners, and researchers. It is written in a policy-oriented style that prioritizes actionable recommendations over abstract theory, making it accessible to readers with a background in public health, international development, or health policy. While the report is technical in its analysis of health system components and aid mechanisms, it avoids unnecessary jargon and presents its arguments in a structured, evidence-based manner. Graduate students and faculty in global health, public policy, and international relations will find it a valuable case study in how high-level policy committees synthesize evidence and formulate recommendations.
Since its publication, the report has contributed to ongoing debates about the future of global health financing and the role of the United States as a donor. Its emphasis on country ownership, outcome measurement, and the integration of vertical and horizontal approaches has resonated with broader trends in the development community, including the movement toward universal health coverage [citation:9]. The report's warnings about the consequences of neglecting health systems—illustrated by the Ebola crisis—have been borne out by subsequent events, reinforcing its central argument. For readers seeking to understand the evolution of U.S. global health policy and the rationale for shifting from disease-specific aid to systems strengthening, this volume provides a concise, authoritative, and historically grounded analysis. It remains a relevant reference for anyone interested in the intersection of health, development, and foreign policy.
Key Features
- The report provides a comprehensive historical overview of U.S. investment in global health programs over the preceding 25 years, with particular attention to the successes and limitations of PEPFAR.
- It offers a rigorous analysis of the debate between vertical and horizontal health programming, arguing for their judicious integration rather than the dominance of either approach.
- The committee presents three specific recommendations for a new donor strategy, including a focus on country ownership, investment in research and training, and rigorous impact evaluation.
- It examines the changing geography of global poverty, explaining why traditional aid models are ill-suited to middle-income countries and fragile states.
- The report explicitly connects health systems strengthening to pandemic preparedness, using the 2014 Ebola outbreak as a case study in the consequences of neglect [citation:2].
- It quantifies the potential impact of modest increases in health spending, noting that a 2 percent increase in current expenditures could underwrite transformative investments [citation:2].
- The volume includes detailed committee member biographies, providing transparency about the expertise and backgrounds of those responsible for the recommendations [citation:8].
- It addresses the financial burden of health expenses on the poor, noting that 150 million people fall into poverty each year because of health costs [citation:9].
- The report argues that building local capacity is a long-term process that requires a longer time frame for development projects than Congress has previously allowed [citation:9].
- It emphasizes the importance of measuring outcomes rather than inputs, shifting the focus from what donors contribute to what their contributions actually produce [citation:2].
- The committee includes experts from diplomacy, medicine, and academia, ensuring a multidisciplinary perspective on global health systems.
About Author
The Institute of Medicine (IOM), now known as the National Academy of Medicine, is a nonprofit, non-governmental organization that was established in 1970 as part of the National Academies of Sciences, Engineering, and Medicine. Its mission is to provide independent, objective analysis and advice to the nation on health and health care. The IOM convenes committees of volunteer experts from diverse fields to study complex health issues and produce consensus reports, such as the one at hand, that inform policy decisions. The Board on Global Health, under whose auspices this report was produced, focuses on international health challenges and the role of the United States in addressing them. The Committee on Investing in Health Systems in Low- and Middle-Income Countries was specifically tasked with examining the future of U.S. global health assistance and developing recommendations for a sustainable strategy.
Ambassador John E. Lange (Ret.) served as co-chair of the committee. He is a former U.S. ambassador to Botswana and had a 28-year career in the Foreign Service, including roles as Special Representative on Avian and Pandemic Influenza and Deputy U.S. Global AIDS Coordinator at the inception of PEPFAR [citation:5][citation:8]. At the time of the report, he was Senior Fellow for Global Health Diplomacy at the United Nations Foundation. Dr. E. Anne Peterson, the other co-chair, brought extensive experience in public health and policy. She served as Assistant Administrator for Global Health at USAID from 2000 to 2005, overseeing programs including PEPFAR, and later held positions at the Ponce School of Medicine and George Washington University [citation:8][citation:11]. She earned her M.D. from the Mayo Medical School and her M.P.H. from Emory University . Gillian J. Buckley served as an editor and study director for the committee, contributing to the report's synthesis and presentation.
Related Books
- Crossing the Quality Chasm: A New Health System for the 21st Century — Institute of Medicine
- The Future of Public Health — Institute of Medicine
- Global Health 101 — Richard Skolnik
- Disease Control Priorities in Developing Countries — Dean T. Jamison, Joel G. Breman, Anthony R. Measham, et al.
- PEPFAR Implementation: Progress and Promise — Institute of Medicine
- The Health of Nations: Why Inequality Is Harmful to Your Health — Ichiro Kawachi and Bruce P. Kennedy
- Global Health: Diseases, Programs, Systems, and Policies — Michael H. Merson, Robert E. Black, and Anne J. Mills
Ads
FAQ
Q : Who were the co-chairs of the committee that produced this report?
R : The committee was co-chaired by Ambassador John E. Lange (Ret.) and Dr. E. Anne Peterson. Lange is a former U.S. ambassador to Botswana with extensive experience in global health diplomacy, including service as Deputy U.S. Global AIDS Coordinator at the inception of PEPFAR [citation:5]. Peterson is a physician and public health expert who served as Assistant Administrator for Global Health at USAID from 2000 to 2005, overseeing programs including PEPFAR [citation:8][citation:11]. Their combined expertise in diplomacy and public health policy shaped the report's recommendations for a more sustainable and effective U.S. global health strategy.
Q : What is the core argument of the report regarding vertical versus horizontal health programs?
R : The report acknowledges the significant successes of vertical programs, particularly PEPFAR, in addressing specific diseases like HIV/AIDS. However, it argues that protecting these gains and preparing for future health challenges requires integrating vertical programs with local health systems—the horizontal approach. A strong health system provides the foundation for both routine care and emergency response, and without it, disease-specific gains remain fragile. The committee recommends that future U.S. aid emphasize health systems strengthening while still supporting targeted interventions where appropriate [citation:2][citation:3].
Q : How does the report address the challenge of poverty in middle-income countries?
R : The report notes that the majority of the approximately one billion people living in extreme poverty now reside in middle-income countries, where foreign assistance may not be needed or welcomed. This represents a significant shift from the historical assumption that poverty is concentrated in the poorest countries. The committee argues that aid strategies must adapt to this new reality, focusing on technical cooperation, knowledge transfer, and support for country-led priorities rather than simply providing financial assistance [citation:3][citation:7]. This nuanced approach recognizes that different contexts require different tools.
Q : What role does the report assign to the United States' scientific and technological strengths?
R : The committee recommends that the United States leverage its comparative advantage in science and technology by investing more in global health research and professional training for students and researchers in developing countries. This includes directing American scientists toward questions that benefit the poor, particularly in implementation research and the development of medicines, vaccines, and diagnostics. Such investment is framed as a transformative approach that builds local capacity and reduces long-term dependence on foreign aid, rather than simply funding service delivery [citation:2].
Q : How does the Ebola outbreak factor into the report's analysis?
R : The report was released in September 2014, during the West African Ebola outbreak, and it explicitly references the crisis as an illustration of its central argument. The committee notes that the same health system components essential for routine care—trained workforce, surveillance systems, laboratory infrastructure, and management capacity—are also critical for emergency response. The Ebola outbreak demonstrated the consequences of neglecting health systems development, as affected countries struggled to contain the epidemic due to weak infrastructure. The report argues that investments in health systems serve dual purposes: improving daily health outcomes and building resilience against future crises [citation:2].
Q : What specific recommendations does the report make for congressional action?
R : The committee recommends that Congress direct more health aid toward health systems building, with three key components. First, future programming should emphasize technical cooperation and country ownership, making investments over longer time periods and measuring outcomes rather than inputs. Second, the United States should invest more in global health research and professional training, leveraging its scientific strengths. Third, Congress should require rigorous external impact evaluations for projects involving technical innovation or new service delivery models. These recommendations aim to make U.S. aid more effective and sustainable [citation:2].
Q : Is this report still relevant given the changes in global health since 2014?
R : Yes, the report's core arguments remain highly relevant. The tension between vertical and horizontal programming, the challenge of reaching the poor in middle-income and fragile states, and the need for country ownership and outcome measurement are enduring issues in global health policy. The COVID-19 pandemic further reinforced the report's warnings about the consequences of weak health systems and the importance of pandemic preparedness. While specific programs and funding levels have changed, the strategic framework the committee proposed—shifting from a focus on inputs to outcomes, and from dependence to sustainability—continues to inform debates about the future of global health assistance.
Q : How does the report define "health systems strengthening"?
R : The report describes health systems as comprising multiple interconnected components: the workforce, leadership and governance, information systems, service delivery, and financing. Strengthening these systems means investing in all of these areas to create a foundation that can support both routine health services and emergency response. The committee emphasizes that this is not a vague or abstract concept but a concrete set of investments in people, infrastructure, data, and management capacity. It argues that such investments are essential for reducing premature mortality, fostering economic growth, and enhancing global security [citation:9][citation:2].
Enregistrer un commentaire
Thanks for comment